|

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

RECRUITINGSponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2023-07-10
Est. completion2026-06-07
Eligibility
Age18 Years – 85 Years
View on ClinicalTrials.gov →

NCT05950503

Summary

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Eligibility

Age: 18 Years – 85 Years
Inclusion Criteria:

* Age \> 18 years;
* Histological diagnosis of colorectal cancer;
* Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
* At least one measurable liver lesion according to RECIST 1.1 criteria;
* Adequate organ and marrow function.

Exclusion Criteria:

* Age \< 18 years;
* Inability to undergo MRI;
* Major contraindications to liver surgery;
* No written informed consent.

Conditions2

CancerColorectal Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.